High-Throughput Image-Based Aggresome Quantification.


Journal

SLAS discovery : advancing life sciences R & D
ISSN: 2472-5560
Titre abrégé: SLAS Discov
Pays: United States
ID NLM: 101697563

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 26 5 2020
medline: 16 7 2021
entrez: 26 5 2020
Statut: ppublish

Résumé

Aggresomes are subcellular perinuclear structures where misfolded proteins accumulate by retrograde transport on microtubules. Different methods are available to monitor aggresome formation, but they are often laborious, time-consuming, and not quantitative. Proteostat is a red fluorescent molecular rotor dye, which becomes brightly fluorescent when it binds to protein aggregates. As this reagent was previously validated to detect aggresomes, we have miniaturized its use in 384-well plates and developed a method for high-throughput imaging and quantification of aggresomes. Two different image analysis methods, including one with machine learning, were evaluated. They lead to similar robust data to quantify cells having aggresome, with satisfactory Z' factor values and reproducible EC

Identifiants

pubmed: 32449635
doi: 10.1177/2472555220919708
pii: S2472-5552(22)06609-6
doi:

Substances chimiques

Proteasome Inhibitors 0
Protein Aggregates 0
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

783-791

Auteurs

Laetitia Lesire (L)

Inserm, Institut Pasteur de Lille, U1177-Drugs and Molecules for Living Systems, University of Lille, Lille, France.

Ludovic Chaput (L)

Inserm, Institut Pasteur de Lille, U1177-Drugs and Molecules for Living Systems, University of Lille, Lille, France.

Paulina Cruz De Casas (P)

Inserm, Institut Pasteur de Lille, U1177-Drugs and Molecules for Living Systems, University of Lille, Lille, France.

Fanny Rousseau (F)

Inserm, Institut Pasteur de Lille, U1177-Drugs and Molecules for Living Systems, University of Lille, Lille, France.

Catherine Piveteau (C)

Inserm, Institut Pasteur de Lille, U1177-Drugs and Molecules for Living Systems, University of Lille, Lille, France.

Julie Dumont (J)

Inserm, Institut Pasteur de Lille, U1177-Drugs and Molecules for Living Systems, University of Lille, Lille, France.

David Pointu (D)

Succursale France, GE Healthcare Europe GmbH, Vélizy-Villacoublay, France.

Benoît Déprez (B)

Inserm, Institut Pasteur de Lille, U1177-Drugs and Molecules for Living Systems, University of Lille, Lille, France.

Florence Leroux (F)

Inserm, Institut Pasteur de Lille, U1177-Drugs and Molecules for Living Systems, University of Lille, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH